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Background:  Implantation of bare metal stents (BMS) induces the release not only of particulate debris, but also of soluble vasoconstrictors 
which contribute to microvascular impairment. We have now addressed the potential attenuation of such vasoconstriction by use of paclitaxel 
eluting stents (PES).
Methods:  Using a distal protection/aspiration device, coronary arterial blood was retrieved before and during stent (n = 14 BMS, n = 14 
PES) implantation in patients with saphenous vein aorto-coronary bypass stenosis and analyzed for plasma serotonin and thromboxane B2 
concentrations. Vasoconstriction of rat mesenteric arteries with intact (+E) and denuded (-E) endothelium in response to coronary arterial or 
aspirate plasma was quantified and normalized to that by potassium chloride (KClmax=100%). 
Results:  Coronary arterial plasma before stent implantation induced a vasoconstriction of 30-43% of KClmax, which was independent of 
endothelial integrity. Serotonin-release was 2.2±0.5 μmol/l with BMS and 2.0±0.4 μmol/l with PES, thromboxane B2-release was 26±5 pg/ml with 
BMS and 22±8 pg/ml with PES. BMS-aspirate plasma induced a vasoconstriction of 68±18% (+E) or 93±14%(-E), respectively. In contrast, PES-
aspirate plasma induced only minor vasoconstriction (+E: 8±3, -E: 12±5% of KClmax). Addition of paclitaxel to BMS-aspirate plasma attenuated 
vasoconstriction. PES-aspirate induced microtubular condensation in immunofluorescence microscopy.
Conclusion: Aspirate from PES implantation attenuates vasoconstriction, possibly secondary to microtubular stabilization.
